Theralase Technologies Inc. V.TLT

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:12-billion $ deal, this could be us?

[macman1519]

AND MY FAVOURITE!!!!! 
minimize this, yaz!!!!

LaserStock29 wrote: Bringing back the 'Discover and Develop' deals that should be right front and centre when Patient 9 is treated. 

LaserStock29 wrote: So wheres the deal?  

Im not talking about 10b for multiple drugs in trials etc.. I'm talking about a modest 500-1b discover, develop commercialize deal


Bencro wrote
Novartis R&D chief Vas Narasimhan has told Bloomberg that stem cell treatment prices could offer a benchmark. Stem cell transplants and follow-up treatment can cost upwards of $800,000. He also said the company is looking at pay-for-performance deals.


So have you emailed this guy yet?

LaserStock29 wrote:

Wheres the deal?

image hosting api

bencro wrote: 
Neither Kite or Novartis have offered any hard guidance on pricing, but Novartis R&D chief Vas Narasimhan has told Bloomberg that stem cell treatment prices could offer a benchmark. Stem cell transplants and follow-up treatment can cost upwards of $800,000. He also said the company is looking at pay-for-performance deals.

RELATED: Manufacturing costs loom large for personalized CAR-T cancer meds and their need for speed
-------------------------------------------
Well Bencro send the Novartis R&D chief Vas Narasimhan our Data..... you want a low cost pay for performance... the TLD-1433 + laser combo is the way to go. 

Instant market disruptor.. ... hey.. bonus  work with Merck to phase out BCG over the next 2 years until 2020 and make the transition 'business friendly'


Well get to it bencro....heck send me the email ill do it.

-----------------------------------------------------------------

LaserStock29 wrote:

Ill state the question again but slightly different


I called in to the first fundraise PP Theralase did.. it sold out over night under 24 hours.. it was a deal 

8million split Canada & USA
-Lachmann funced  the 1st 4million
-Europac funded the 2nd 4million

Then 2nd deal was 
-Europac funded us 8million in round 2 of funding


Then Doug Loe basically came out and said Europac isn't funding us anymore. Theralase will need an outside funder. 

So we cycle back to Lachmann (Frost) 
 

People freak out about big 12b deals this but people... ever see how Athletic contracts are dealt out.

Think Non-Guarenteed NFL deals... that's Big Pharma to Pre-Clinical and now Clinical Companies

Theralase uplisted to the QX for the very reason of exposure and to make a deal.. en route to Nasdaq.

NFL contracts say for quarterbacks... 

100million bucks 30 of which is guarenteed to be paid over  X number of years... bonuses on performance milestones

Often times the full amount isn't paid out to the Athletes..



So again, i will bump this post as it's a deal around 'R&D, discovery and development'


Again... Pharma can announce an 800m deal... but in reality... pay 40-50 million upfront ... and guess what.. we do have the pre-clinical Brain work done and much of the Lung pre-clinical work... so that's already two more indications Phase 1b. 

Is this board really gonna sit there and tell us that  Lachmann and Europac put in 16million to develop and move us from Pre-Clinical status to success in 4 patients.... a significant record sellout on time yet 

Big pharma with its multiple billion dollar deals.. wont pick up the 40-50m up front tab and lay out an incentivized deal over time upping valuation?


I am so sorry... maybe playing around with protein interaction has saved more lives. hahaha..not a chance. 


This is a running JOKE... and it's now at the time in January where we have Patient 4 and a big conference... I see no reason why TLT can't DO something.


Have a great day everyone... 


Now that you KNOW how these deals are structured... think about how silly it is... the investment we have already recieved and the claims that big pharma wont commit to us. 

It's on a level of stupidity unbelieveable. IMO. 


 

LaserStock29 wrote: So where is our  $65 million up front with back-loaded incentives over a few years to drive our valuation?   Our results not good enough... 4 bladder saved..??

This is the 815m deal btw.

Forma deal 2012
 

 

FORMA Therapeutics Announces Collaboration with Boehringer Ingelheim to Develop Novel Oncology Drugs

- Alliance to Focus on Multiple Protein-protein Interaction Targets -

January 05, 2012 08:30 AM Eastern Standard Time

WATERTOWN, Mass.--(BUSINESS WIRE)--FORMA Therapeutics announced today that the Company has entered into a research and development collaboration with Boehringer Ingelheim to discover and develop novel drug candidates for the treatment of cancer. The agreement will focus on discovering small molecule drugs against oncology-relevant protein-protein interactions.

“This creative deal provides Boehringer Ingelheim with access to our drug discovery capabilities in cancer but also offers FORMA and our shareholders several opportunities to realize early return through assets developed under this collaboration”

Tweet this

Under the terms of the collaboration, FORMA will receive a total of $65 million in up-front payments and research funding to screen for and optimize compounds against multiple oncology targets over the next four years. FORMA could be eligible for up to $750 million in pre-commercial milestones for programs resulting from the collaboration. Further financial details were not disclosed.

“Many of the ‘un-druggable’ and/or novel targets in oncology involve protein-protein interactions,” said Kenneth Bair, Ph.D., Senior Vice President and Head of Research and Development of FORMA. “We are really excited about tackling these essential targets with Boehringer Ingelheim.”

“This creative deal provides Boehringer Ingelheim with access to our drug discovery capabilities in cancer but also offers FORMA and our shareholders several opportunities to realize early return through assets developed under this collaboration,” commented Steven Tregay, Ph.D., Chief Executive Officer of FORMA.